RWP
OCEA

Revolve Wealth Partners’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Revolve Wealth Partners’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,570
Closed -$3.76K – 245
2025
Q1 		$3.76K Buy
+69,570
New +$16.6K ﹤0.01% 223

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Revolve Wealth Partners's OCEA Position: Q2 2025 in Review

Revolve Wealth Partners sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 69,570 shares — an estimated $3.76K sold.

Revolve Wealth Partners first reported a position in OCEA in Q1 2025 and held it in 1 quarter. The position peaked at $3.76K in Q1 2025. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Revolve Wealth Partners reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Revolve Wealth Partners sold 69,570 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $3.76K.
  • Revolve Wealth Partners first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • Revolve Wealth Partners's Ocean Biomedical, Inc. Common Stock position peaked at $3.76K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Revolve Wealth Partners's 13F filing for Q2 2025, filed 28 Jul 2025.